ArticleLeukemia2007
Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.
E Jost et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled itcites it